R-10 is an investigational peptide compound studied for its activity at three metabolic hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.
The compound is currently being investigated in clinical research, including studies examining metabolic signaling, energy regulation, glucose metabolism, and related biological pathways.
R-10 has not been approved by the U.S. Food and Drug Administration (FDA).
For Research Use Only. Not for human or veterinary use. Not intended for consumption, diagnosis, treatment, cure, or prevention of any disease.
